| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Exposure Delayed Effects | 14 | 2026 | 206 | 5.070 |
Why?
|
| Pregnancy | 67 | 2026 | 1555 | 4.940 |
Why?
|
| Cannabis | 12 | 2025 | 79 | 4.780 |
Why?
|
| Depression | 14 | 2026 | 479 | 4.380 |
Why?
|
| Depression, Postpartum | 7 | 2025 | 27 | 4.340 |
Why?
|
| Pregnancy Complications | 10 | 2026 | 202 | 3.040 |
Why?
|
| Female | 87 | 2026 | 12193 | 2.970 |
Why?
|
| Adult | 64 | 2026 | 7255 | 2.680 |
Why?
|
| Humans | 88 | 2026 | 16832 | 2.540 |
Why?
|
| Alcohol Drinking | 10 | 2025 | 298 | 2.410 |
Why?
|
| California | 27 | 2026 | 2244 | 2.200 |
Why?
|
| Anxiety | 6 | 2024 | 154 | 1.980 |
Why?
|
| Premature Birth | 8 | 2023 | 133 | 1.970 |
Why?
|
| Marijuana Use | 5 | 2025 | 32 | 1.960 |
Why?
|
| Exercise | 5 | 2025 | 513 | 1.650 |
Why?
|
| Telemedicine | 3 | 2025 | 190 | 1.550 |
Why?
|
| Pregnant Women | 3 | 2023 | 41 | 1.530 |
Why?
|
| Stress, Psychological | 8 | 2026 | 136 | 1.410 |
Why?
|
| Hallucinogens | 2 | 2022 | 21 | 1.400 |
Why?
|
| Pregnancy Complications, Infectious | 6 | 2022 | 158 | 1.390 |
Why?
|
| Autism Spectrum Disorder | 2 | 2024 | 165 | 1.350 |
Why?
|
| Prenatal Care | 6 | 2025 | 123 | 1.290 |
Why?
|
| Intimate Partner Violence | 2 | 2023 | 11 | 1.270 |
Why?
|
| Postpartum Period | 4 | 2025 | 89 | 1.250 |
Why?
|
| Cross-Sectional Studies | 9 | 2026 | 1233 | 1.230 |
Why?
|
| Young Adult | 20 | 2026 | 2456 | 1.210 |
Why?
|
| Maternal Exposure | 6 | 2026 | 84 | 1.170 |
Why?
|
| Pandemics | 8 | 2023 | 289 | 1.150 |
Why?
|
| Cohort Studies | 21 | 2026 | 2396 | 1.150 |
Why?
|
| Autistic Disorder | 3 | 2026 | 117 | 1.120 |
Why?
|
| Substance-Related Disorders | 6 | 2022 | 305 | 1.050 |
Why?
|
| Infant, Newborn | 15 | 2025 | 828 | 1.050 |
Why?
|
| Abortion, Spontaneous | 3 | 2014 | 49 | 1.040 |
Why?
|
| Male | 30 | 2026 | 9556 | 0.960 |
Why?
|
| Perinatal Care | 2 | 2016 | 12 | 0.950 |
Why?
|
| Pregnancy Outcome | 6 | 2025 | 160 | 0.940 |
Why?
|
| Nicotine | 2 | 2025 | 25 | 0.910 |
Why?
|
| Adolescent | 21 | 2026 | 3464 | 0.890 |
Why?
|
| Congenital Abnormalities | 1 | 2025 | 26 | 0.890 |
Why?
|
| Mindfulness | 1 | 2025 | 30 | 0.880 |
Why?
|
| Legislation, Drug | 2 | 2024 | 10 | 0.880 |
Why?
|
| Hearing Loss | 1 | 2025 | 14 | 0.860 |
Why?
|
| Anxiety Disorders | 4 | 2023 | 96 | 0.840 |
Why?
|
| Developmental Disabilities | 1 | 2024 | 53 | 0.810 |
Why?
|
| Overweight | 2 | 2022 | 262 | 0.800 |
Why?
|
| Child Development | 2 | 2024 | 58 | 0.790 |
Why?
|
| Child | 16 | 2026 | 2433 | 0.770 |
Why?
|
| Retrospective Studies | 11 | 2025 | 2463 | 0.750 |
Why?
|
| Infant | 11 | 2026 | 1212 | 0.740 |
Why?
|
| Vitamins | 4 | 2022 | 56 | 0.740 |
Why?
|
| Influenza, Human | 4 | 2020 | 292 | 0.730 |
Why?
|
| Pre-Eclampsia | 3 | 2023 | 41 | 0.730 |
Why?
|
| Child, Preschool | 13 | 2026 | 1430 | 0.710 |
Why?
|
| Alcoholism | 7 | 2009 | 235 | 0.700 |
Why?
|
| Environmental Pollutants | 4 | 2026 | 68 | 0.690 |
Why?
|
| Marijuana Abuse | 1 | 2021 | 33 | 0.670 |
Why?
|
| Organophosphates | 3 | 2026 | 20 | 0.670 |
Why?
|
| Flame Retardants | 3 | 2026 | 20 | 0.670 |
Why?
|
| Influenza Vaccines | 4 | 2020 | 300 | 0.670 |
Why?
|
| Dietary Supplements | 3 | 2014 | 83 | 0.660 |
Why?
|
| Temperature | 2 | 2017 | 18 | 0.630 |
Why?
|
| Marijuana Smoking | 1 | 2020 | 40 | 0.600 |
Why?
|
| Health Plan Implementation | 2 | 2016 | 34 | 0.580 |
Why?
|
| Diet | 2 | 2024 | 349 | 0.580 |
Why?
|
| Depressive Disorder | 1 | 2020 | 177 | 0.550 |
Why?
|
| Pediatric Obesity | 3 | 2026 | 101 | 0.540 |
Why?
|
| Spouse Abuse | 1 | 2017 | 8 | 0.530 |
Why?
|
| Risk Factors | 9 | 2026 | 3108 | 0.510 |
Why?
|
| Alcoholics Anonymous | 4 | 2011 | 6 | 0.510 |
Why?
|
| Risk-Taking | 2 | 2009 | 92 | 0.490 |
Why?
|
| Outcome Assessment (Health Care) | 2 | 2016 | 199 | 0.490 |
Why?
|
| United States | 15 | 2026 | 3858 | 0.460 |
Why?
|
| Temperance | 3 | 2012 | 10 | 0.450 |
Why?
|
| Health | 2 | 2015 | 26 | 0.450 |
Why?
|
| Adaptation, Psychological | 3 | 2025 | 76 | 0.440 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2015 | 8 | 0.440 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2015 | 17 | 0.440 |
Why?
|
| Computers | 1 | 2014 | 5 | 0.440 |
Why?
|
| Dietary Carbohydrates | 1 | 2014 | 28 | 0.430 |
Why?
|
| Surveys and Questionnaires | 10 | 2026 | 1204 | 0.430 |
Why?
|
| Carbonated Beverages | 1 | 2014 | 15 | 0.430 |
Why?
|
| Beer | 1 | 2014 | 9 | 0.420 |
Why?
|
| Wine | 1 | 2014 | 17 | 0.410 |
Why?
|
| Aging | 2 | 2015 | 146 | 0.410 |
Why?
|
| Antiviral Agents | 2 | 2014 | 92 | 0.410 |
Why?
|
| Mental Health | 3 | 2025 | 161 | 0.410 |
Why?
|
| Pregnancy Trimester, First | 1 | 2014 | 45 | 0.410 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2014 | 22 | 0.400 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2024 | 55 | 0.400 |
Why?
|
| Counseling | 1 | 2014 | 170 | 0.390 |
Why?
|
| Delivery of Health Care | 4 | 2023 | 374 | 0.370 |
Why?
|
| Life Tables | 1 | 2012 | 7 | 0.360 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2011 | 4 | 0.350 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2011 | 35 | 0.340 |
Why?
|
| Prospective Studies | 7 | 2026 | 1186 | 0.340 |
Why?
|
| African Continental Ancestry Group | 1 | 2011 | 117 | 0.330 |
Why?
|
| Social Support | 3 | 2011 | 195 | 0.330 |
Why?
|
| Breast Feeding | 2 | 2026 | 112 | 0.330 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2022 | 40 | 0.320 |
Why?
|
| Body Mass Index | 4 | 2026 | 925 | 0.320 |
Why?
|
| Community Mental Health Services | 2 | 2008 | 30 | 0.320 |
Why?
|
| Social Environment | 2 | 2008 | 77 | 0.320 |
Why?
|
| Middle Aged | 13 | 2025 | 7515 | 0.320 |
Why?
|
| Patient Compliance | 2 | 2009 | 262 | 0.310 |
Why?
|
| European Continental Ancestry Group | 1 | 2011 | 400 | 0.300 |
Why?
|
| Diabetes, Gestational | 3 | 2026 | 330 | 0.290 |
Why?
|
| Mass Screening | 1 | 2014 | 670 | 0.290 |
Why?
|
| Child Health | 2 | 2026 | 41 | 0.290 |
Why?
|
| Ambulatory Care Facilities | 1 | 2009 | 60 | 0.280 |
Why?
|
| Psychometrics | 3 | 2023 | 114 | 0.280 |
Why?
|
| Interpersonal Relations | 2 | 2008 | 38 | 0.280 |
Why?
|
| Longitudinal Studies | 4 | 2024 | 653 | 0.270 |
Why?
|
| Sexual Behavior | 1 | 2009 | 112 | 0.270 |
Why?
|
| Electronic Health Records | 2 | 2026 | 702 | 0.270 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2025 | 317 | 0.250 |
Why?
|
| Hispanic Americans | 2 | 2020 | 350 | 0.240 |
Why?
|
| Seasons | 2 | 2017 | 114 | 0.240 |
Why?
|
| Risk Assessment | 4 | 2020 | 1047 | 0.240 |
Why?
|
| Plasticizers | 1 | 2026 | 5 | 0.240 |
Why?
|
| Prevalence | 6 | 2014 | 785 | 0.240 |
Why?
|
| Maternal Health Services | 2 | 2016 | 11 | 0.240 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2026 | 66 | 0.240 |
Why?
|
| Firearms | 1 | 2026 | 32 | 0.230 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2025 | 3 | 0.230 |
Why?
|
| Lactation | 1 | 2026 | 37 | 0.230 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2025 | 5 | 0.230 |
Why?
|
| Decision Support Techniques | 1 | 2026 | 87 | 0.230 |
Why?
|
| Gastroschisis | 1 | 2025 | 1 | 0.230 |
Why?
|
| Computational Biology | 1 | 2015 | 20 | 0.230 |
Why?
|
| Genotyping Techniques | 1 | 2015 | 24 | 0.230 |
Why?
|
| Fluorocarbons | 1 | 2025 | 20 | 0.220 |
Why?
|
| Maternal Age | 2 | 2017 | 73 | 0.220 |
Why?
|
| Child Behavior | 1 | 2025 | 25 | 0.220 |
Why?
|
| Genomics | 1 | 2015 | 54 | 0.220 |
Why?
|
| Health Personnel | 1 | 2026 | 132 | 0.220 |
Why?
|
| Smoking | 3 | 2017 | 373 | 0.210 |
Why?
|
| Self-Help Groups | 1 | 2004 | 22 | 0.210 |
Why?
|
| Health Status | 1 | 2026 | 256 | 0.210 |
Why?
|
| Marital Status | 1 | 2004 | 17 | 0.210 |
Why?
|
| Social Segregation | 1 | 2023 | 2 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 311 | 0.200 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2015 | 353 | 0.200 |
Why?
|
| Continental Population Groups | 1 | 2015 | 255 | 0.200 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2025 | 515 | 0.200 |
Why?
|
| Eclampsia | 1 | 2023 | 13 | 0.200 |
Why?
|
| Primary Health Care | 1 | 2009 | 693 | 0.200 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2023 | 5 | 0.190 |
Why?
|
| Mental Disorders | 1 | 2026 | 248 | 0.190 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2022 | 8 | 0.190 |
Why?
|
| Folic Acid | 1 | 2022 | 29 | 0.190 |
Why?
|
| Analgesics | 1 | 2022 | 25 | 0.190 |
Why?
|
| Central Nervous System Stimulants | 1 | 2022 | 23 | 0.180 |
Why?
|
| Socioeconomic Factors | 5 | 2017 | 571 | 0.180 |
Why?
|
| Drug Utilization | 2 | 2013 | 112 | 0.180 |
Why?
|
| Ethnic Groups | 1 | 2015 | 418 | 0.180 |
Why?
|
| Labetalol | 1 | 2022 | 9 | 0.180 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 34 | 0.180 |
Why?
|
| Cannabinoids | 1 | 2021 | 6 | 0.180 |
Why?
|
| Calcineurin Inhibitors | 1 | 2020 | 2 | 0.160 |
Why?
|
| Cholesterol, HDL | 1 | 2021 | 64 | 0.160 |
Why?
|
| Triglycerides | 1 | 2021 | 78 | 0.160 |
Why?
|
| Glucocorticoids | 1 | 2020 | 22 | 0.160 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2020 | 23 | 0.160 |
Why?
|
| Dermatitis, Atopic | 1 | 2020 | 18 | 0.160 |
Why?
|
| Gestational Age | 3 | 2023 | 118 | 0.160 |
Why?
|
| Self Medication | 1 | 2020 | 5 | 0.160 |
Why?
|
| Psychological Trauma | 1 | 2020 | 6 | 0.160 |
Why?
|
| Ideal Body Weight | 1 | 2020 | 10 | 0.160 |
Why?
|
| Time Factors | 2 | 2014 | 989 | 0.160 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2020 | 10 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 55 | 0.150 |
Why?
|
| Fruit | 1 | 2020 | 79 | 0.150 |
Why?
|
| Vegetables | 1 | 2020 | 88 | 0.150 |
Why?
|
| Obesity | 2 | 2022 | 811 | 0.150 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 23 | 0.150 |
Why?
|
| Ethanol | 2 | 2023 | 19 | 0.150 |
Why?
|
| Energy Intake | 1 | 2020 | 98 | 0.150 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 59 | 0.150 |
Why?
|
| Vaccines, Inactivated | 1 | 2020 | 73 | 0.150 |
Why?
|
| HIV Infections | 1 | 2005 | 708 | 0.140 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 1058 | 0.140 |
Why?
|
| Women's Health | 2 | 2021 | 178 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2013 | 1098 | 0.130 |
Why?
|
| Weather | 1 | 2017 | 2 | 0.130 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 47 | 0.130 |
Why?
|
| Pregnancy Trimesters | 1 | 2016 | 27 | 0.120 |
Why?
|
| Drug Prescriptions | 2 | 2020 | 137 | 0.120 |
Why?
|
| Risk | 2 | 2014 | 453 | 0.120 |
Why?
|
| Medicaid | 1 | 2017 | 189 | 0.110 |
Why?
|
| Data Collection | 2 | 2007 | 223 | 0.110 |
Why?
|
| Molecular Epidemiology | 2 | 2015 | 33 | 0.110 |
Why?
|
| Population Surveillance | 2 | 2014 | 242 | 0.110 |
Why?
|
| Esters | 2 | 2025 | 10 | 0.110 |
Why?
|
| Hypertension | 1 | 2020 | 475 | 0.110 |
Why?
|
| Herpes Genitalis | 1 | 2014 | 3 | 0.110 |
Why?
|
| Labor, Induced | 1 | 2014 | 5 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2016 | 294 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2014 | 108 | 0.110 |
Why?
|
| Health Behavior | 2 | 2014 | 332 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2014 | 64 | 0.100 |
Why?
|
| Medical Records | 1 | 2014 | 85 | 0.100 |
Why?
|
| African Americans | 1 | 2017 | 394 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2014 | 210 | 0.100 |
Why?
|
| Accelerometry | 2 | 2025 | 48 | 0.100 |
Why?
|
| Sleep | 2 | 2025 | 54 | 0.100 |
Why?
|
| Insurance Coverage | 1 | 2014 | 102 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 76 | 0.100 |
Why?
|
| Preventive Health Services | 1 | 2014 | 142 | 0.100 |
Why?
|
| Prescriptions | 1 | 2013 | 28 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2012 | 9 | 0.090 |
Why?
|
| Epilepsy | 1 | 2012 | 14 | 0.090 |
Why?
|
| Educational Status | 3 | 2023 | 163 | 0.090 |
Why?
|
| Schizophrenia | 1 | 2013 | 75 | 0.090 |
Why?
|
| Antipsychotic Agents | 1 | 2013 | 50 | 0.090 |
Why?
|
| Databases, Bibliographic | 1 | 2012 | 6 | 0.090 |
Why?
|
| Abortion, Induced | 1 | 2012 | 16 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2013 | 127 | 0.090 |
Why?
|
| Mothers | 2 | 2022 | 104 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 247 | 0.080 |
Why?
|
| Vaccination | 1 | 2015 | 725 | 0.080 |
Why?
|
| Antihypertensive Agents | 2 | 2022 | 157 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2026 | 352 | 0.070 |
Why?
|
| South Africa | 1 | 2009 | 12 | 0.070 |
Why?
|
| Tobacco | 2 | 2023 | 8 | 0.070 |
Why?
|
| Logistic Models | 3 | 2017 | 796 | 0.060 |
Why?
|
| Helping Behavior | 1 | 2007 | 2 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2026 | 81 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 410 | 0.060 |
Why?
|
| Sex Factors | 1 | 2008 | 560 | 0.060 |
Why?
|
| Day Care, Medical | 1 | 2005 | 1 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 18 | 0.060 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 21 | 0.060 |
Why?
|
| Pedigree | 1 | 2015 | 27 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2026 | 305 | 0.060 |
Why?
|
| Quality Control | 1 | 2015 | 37 | 0.060 |
Why?
|
| Demography | 1 | 2005 | 89 | 0.060 |
Why?
|
| Outcome and Process Assessment (Health Care) | 1 | 2005 | 85 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2026 | 197 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 489 | 0.050 |
Why?
|
| Biomarkers | 1 | 2025 | 284 | 0.050 |
Why?
|
| Aged | 3 | 2020 | 5901 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 305 | 0.050 |
Why?
|
| Probability | 1 | 2004 | 66 | 0.050 |
Why?
|
| Motivation | 1 | 2004 | 103 | 0.050 |
Why?
|
| Censuses | 1 | 2023 | 30 | 0.050 |
Why?
|
| Stillbirth | 1 | 2023 | 29 | 0.050 |
Why?
|
| Self Report | 1 | 2024 | 248 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 346 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 10 | 0.050 |
Why?
|
| Opioid-Related Disorders | 1 | 2005 | 174 | 0.050 |
Why?
|
| Methyldopa | 1 | 2022 | 6 | 0.050 |
Why?
|
| Nifedipine | 1 | 2022 | 6 | 0.050 |
Why?
|
| Keratinocytes | 1 | 2020 | 5 | 0.040 |
Why?
|
| Menopause | 1 | 2021 | 60 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2021 | 113 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 239 | 0.040 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2020 | 99 | 0.040 |
Why?
|
| Weight Gain | 1 | 2020 | 167 | 0.040 |
Why?
|
| Program Evaluation | 2 | 2012 | 211 | 0.030 |
Why?
|
| Hospitalization | 1 | 2023 | 816 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1229 | 0.030 |
Why?
|
| Environment | 1 | 2016 | 47 | 0.030 |
Why?
|
| Managed Care Programs | 1 | 2016 | 275 | 0.030 |
Why?
|
| Obstetric Labor Complications | 1 | 2014 | 11 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 319 | 0.030 |
Why?
|
| Preconception Care | 1 | 2014 | 43 | 0.030 |
Why?
|
| Oregon | 1 | 2013 | 168 | 0.020 |
Why?
|
| Infertility, Female | 1 | 2013 | 11 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2013 | 22 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2014 | 184 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2013 | 29 | 0.020 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2013 | 18 | 0.020 |
Why?
|
| Binge Drinking | 1 | 2012 | 8 | 0.020 |
Why?
|
| Metformin | 1 | 2013 | 49 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 84 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2013 | 201 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 995 | 0.020 |
Why?
|
| Antisocial Personality Disorder | 1 | 2006 | 2 | 0.010 |
Why?
|
| Marriage | 1 | 2006 | 3 | 0.010 |
Why?
|
| Behavior | 1 | 2006 | 14 | 0.010 |
Why?
|
| Military Personnel | 1 | 2006 | 13 | 0.010 |
Why?
|
| Aggression | 1 | 2006 | 19 | 0.010 |
Why?
|
| Episode of Care | 1 | 2005 | 8 | 0.010 |
Why?
|
| Aftercare | 1 | 2005 | 46 | 0.010 |
Why?
|
| Family | 1 | 2006 | 99 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 64 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 149 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2005 | 98 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 229 | 0.010 |
Why?
|
| Parents | 1 | 2006 | 298 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 262 | 0.010 |
Why?
|